Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 30-Sep-24 4:30 PM View:  | O'Malley Brendan M. SVP, General Counsel | Access Pharmaceuticals Inc. (ABEO) | 28-Sep-24 | Payment of Exercise | 6,579 | $5.89 | $38,750.30 | (2%) 279.87K to 273.29K | |
| 30-Sep-24 4:30 PM View: | Seshadri Vishwas Chief Executive Officer Director | Access Pharmaceuticals Inc. (ABEO) | 28-Sep-24 | Payment of Exercise | 18,798 | $5.89 | $110,720.00 | (2%) 922.94K to 904.14K | |
| 30-Sep-24 4:30 PM View: | Vazzano Joseph Walter Chief Financial Officer | Access Pharmaceuticals Inc. (ABEO) | 28-Sep-24 | Payment of Exercise | 6,388 | $5.89 | $37,625.30 | (2%) 371.61K to 365.22K | |
| 24-Sep-24 4:30 PM View: | O'Malley Brendan M. SVP, General Counsel | Access Pharmaceuticals Inc. (ABEO) | 20-Sep-24 | Payment of Exercise | 496 | $6.02 | $2,985.92 | (< 1%) 280.36K to 279.87K | |
| 27-Aug-24 7:08 PM View: | Charles Faith L. Director | Access Pharmaceuticals Inc. (ABEO) | 26-Aug-24 | Grant | 11,797 | -- | -- | 12% 101.93K to 113.73K | |
| 27-Aug-24 7:10 PM View: | Wuchterl Donald A. Director | Access Pharmaceuticals Inc. (ABEO) | 26-Aug-24 | Grant | 11,797 | -- | -- | 11% 102.71K to 114.51K | |
| 27-Aug-24 7:09 PM View: | Silverstein Christine Berni Director | Access Pharmaceuticals Inc. (ABEO) | 26-Aug-24 | Grant | 11,797 | -- | -- | 14% 85.67K to 97.47K | |
| 27-Aug-24 7:05 PM View: | Alland Leila Director | Access Pharmaceuticals Inc. (ABEO) | 26-Aug-24 | Grant | 11,797 | -- | -- | 11% 106.47K to 118.27K | |
| 27-Aug-24 7:07 PM View: | Amoroso Michael Director | Access Pharmaceuticals Inc. (ABEO) | 26-Aug-24 | Grant | 11,797 | -- | -- | 9% 132.57K to 144.37K | |
| 27-Aug-24 7:06 PM View: | Alvino Mark Director | Access Pharmaceuticals Inc. (ABEO) | 26-Aug-24 | Grant | 11,797 | -- | -- | 19% 60.54K to 72.33K | |
| 14-Aug-24 5:10 PM View: | Crombez Eric Director | Access Pharmaceuticals Inc. (ABEO) | 13-Aug-24 | Grant | 11,044 | -- | -- | 100% 0 to 11.04K | |
| 14-Aug-24 5:10 PM View: | Zeiher Bernhardt G Director | Access Pharmaceuticals Inc. (ABEO) | 13-Aug-24 | Grant | 11,044 | -- | -- | 100% 0 to 11.04K | |
| 22-Jul-24 4:30 PM View: | Vazzano Joseph Walter Chief Financial Officer | Access Pharmaceuticals Inc. (ABEO) | 21-Jul-24 | Payment of Exercise | 1,055 | $5.11 | $5,391.05 | (< 1%) 372.66K to 371.61K | |
| 09-Jul-24 4:35 PM View: | Silverstein Christine Berni Director | Access Pharmaceuticals Inc. (ABEO) | 08-Jul-24 | Grant | 23,611 | -- | -- | 38% 62.06K to 85.67K | |
| 09-Jul-24 4:35 PM View: | Charles Faith L. Director | Access Pharmaceuticals Inc. (ABEO) | 08-Jul-24 | Grant | 23,611 | -- | -- | 30% 78.32K to 101.93K | |
| 09-Jul-24 4:35 PM View: | O'Malley Brendan M. SVP, General Counsel | Access Pharmaceuticals Inc. (ABEO) | 08-Jul-24 | Grant | 102,689 | -- | -- | 58% 177.68K to 280.36K | |
| 09-Jul-24 4:35 PM View: | Alland Leila Director | Access Pharmaceuticals Inc. (ABEO) | 08-Jul-24 | Grant | 23,611 | -- | -- | 28% 82.86K to 106.47K | |
| 09-Jul-24 4:35 PM View: | Wuchterl Donald A. Director | Access Pharmaceuticals Inc. (ABEO) | 08-Jul-24 | Grant | 23,611 | -- | -- | 30% 79.1K to 102.71K | |
| 09-Jul-24 4:35 PM View: | Alvino Mark Director | Access Pharmaceuticals Inc. (ABEO) | 08-Jul-24 | Grant | 23,611 | -- | -- | 64% 36.93K to 60.54K | |
| 09-Jul-24 4:35 PM View: | Amoroso Michael Director | Access Pharmaceuticals Inc. (ABEO) | 08-Jul-24 | Grant | 23,611 | -- | -- | 22% 108.96K to 132.57K | |
| 09-Jul-24 4:35 PM View: | Seshadri Vishwas Chief Executive Officer Director | Access Pharmaceuticals Inc. (ABEO) | 08-Jul-24 | Grant | 424,000 | -- | -- | 85% 498.94K to 922.94K | |
| 09-Jul-24 4:35 PM View: | Vazzano Joseph Walter Chief Financial Officer | Access Pharmaceuticals Inc. (ABEO) | 08-Jul-24 | Grant | 155,200 | -- | -- | 71% 217.46K to 372.66K | |
| 20-Jun-24 4:30 PM View: | Silverstein Christine Berni Director | Access Pharmaceuticals Inc. (ABEO) | 18-Jun-24 | Private Sale | 25,821 | $4.51 | $116,453.00 | (29%) 87.88K to 62.06K | |
| 20-Jun-24 4:30 PM View: | Alvino Mark Director | Access Pharmaceuticals Inc. (ABEO) | 18-Jun-24 | Private Sale | 25,890 | $4.51 | $116,764.00 | (41%) 62.82K to 36.93K | |
| 07-Jun-24 4:33 PM View: | Vazzano Joseph Walter Chief Financial Officer | Access Pharmaceuticals Inc. (ABEO) | 05-Jun-24 | Payment of Exercise | 16,408 | $4.52 | $74,164.20 | (7%) 233.87K to 217.46K | |
| 07-Jun-24 4:32 PM View: | Seshadri Vishwas Chief Executive Officer Director | Access Pharmaceuticals Inc. (ABEO) | 05-Jun-24 | Payment of Exercise | 38,621 | $4.52 | $174,567.00 | (7%) 537.56K to 498.94K | |
| 07-Jun-24 4:31 PM View: | O'Malley Brendan M. SVP, General Counsel | Access Pharmaceuticals Inc. (ABEO) | 05-Jun-24 | Payment of Exercise | 10,951 | $4.52 | $49,498.50 | (6%) 188.63K to 177.68K | |
| 05-Jun-24 4:30 PM View: | Seshadri Vishwas Chief Executive Officer Director | Access Pharmaceuticals Inc. (ABEO) | 03-Jun-24 | Payment of Exercise | 703 | $4.38 | $3,079.14 | (< 1%) 538.26K to 537.56K | |
| 20-May-24 8:30 AM View: | Alland Leila Director | Access Pharmaceuticals Inc. (ABEO) | 16-May-24 | Purchase | 11,000 | $4.71 | $51,799.00 | 15% 71.86K to 82.86K | |
| 29-Apr-24 8:30 AM View: | Charles Faith L. Director | Access Pharmaceuticals Inc. (ABEO) | 26-Apr-24 | Purchase | 7,550 | $3.28 | $24,764.00 | 11% 70.77K to 78.32K | |
| 29-Apr-24 8:30 AM View: | Seshadri Vishwas Chief Executive Officer Director | Access Pharmaceuticals Inc. (ABEO) | 25-Apr-24 | Purchase | 10,000 | $3.20 | $32,000.00 | 2% 528.26K to 538.26K | |
| 26-Apr-24 8:30 AM View: | Vazzano Joseph Walter Chief Financial Officer | Access Pharmaceuticals Inc. (ABEO) | 25-Apr-24 | Purchase | 5,608 | $3.14 | $17,609.10 | 2% 228.26K to 233.87K | |
| 26-Apr-24 8:30 AM View: | O'Malley Brendan M. SVP, General Counsel | Access Pharmaceuticals Inc. (ABEO) | 25-Apr-24 | Purchase | 8,600 | $3.24 | $27,864.00 | 5% 180.12K to 188.72K | |
| 07-Jun-24 4:30 PM View: | O'Malley Brendan M. SVP, General Counsel | Access Pharmaceuticals Inc. (ABEO) | 31-Mar-24 | Payment of Exercise | 92 | $7.25 | $667.00 | (< 1%) 180.12K to 180.03K | |
| 15-Mar-24 5:00 PM View: | Vazzano Joseph Walter Chief Financial Officer | Access Pharmaceuticals Inc. (ABEO) | 15-Mar-24 | Payment of Exercise | 703 | $8.14 | $5,722.42 | (< 1%) 228.96K to 228.26K | |
| 12-Mar-24 5:00 PM View: | O'Malley Brendan M. SVP, General Counsel | Access Pharmaceuticals Inc. (ABEO) | 04-Mar-24 | Payment of Exercise | 183 | $7.81 | $1,429.23 | (< 1%) 180.3K to 180.12K | |
| 07-Feb-24 8:30 AM View: | Seshadri Vishwas Chief Executive Officer Director | Access Pharmaceuticals Inc. (ABEO) | 06-Feb-24 | Purchase | 20,000 | $4.39 | $87,800.00 | 4% 508.26K to 528.26K | |
| 22-Jan-24 4:30 PM View: | Alvino Mark Director | Access Pharmaceuticals Inc. (ABEO) | 17-Jan-24 | Private Sale | 7,084 | $5.11 | $36,199.20 | (10%) 69.9K to 62.82K | |
| 17-Oct-23 4:30 PM View: | Seshadri Vishwas Chief Executive Officer Director | Access Pharmaceuticals Inc. (ABEO) | 16-Oct-23 | Payment of Exercise | 181 | $4.14 | $749.34 | (< 1%) 508.44K to 508.26K | |
| 29-Sep-23 5:16 PM View: | O'Malley Brendan M. SVP, General Counsel | Access Pharmaceuticals Inc. (ABEO) | 29-Sep-23 | Payment of Exercise | 6,557 | $3.93 | $25,769.00 | (4%) 186.86K to 180.3K | |
| 29-Sep-23 5:17 PM View: | Vazzano Joseph Walter Chief Financial Officer | Access Pharmaceuticals Inc. (ABEO) | 29-Sep-23 | Payment of Exercise | 6,230 | $3.93 | $24,483.90 | (3%) 235.19K to 228.96K | |
| 29-Sep-23 5:25 PM View: | Seshadri Vishwas Chief Executive Officer Director | Access Pharmaceuticals Inc. (ABEO) | 29-Sep-23 | Payment of Exercise | 13,290 | $3.93 | $52,229.70 | (3%) 521.73K to 508.44K | |
| 29-Sep-23 4:30 PM View: | Amoroso Michael Director | Access Pharmaceuticals Inc. (ABEO) | 27-Sep-23 | Private Sale | 5,508 | $3.91 | $21,542.30 | (5%) 114.47K to 108.96K | |
| 29-Sep-23 4:30 PM View: | Charles Faith L. Director | Access Pharmaceuticals Inc. (ABEO) | 27-Sep-23 | Private Sale | 8,330 | $4.91 | $40,923.60 | (11%) 79.1K to 70.77K | |
| 29-Sep-23 7:30 AM View: | Seshadri Vishwas Chief Executive Officer Director | Access Pharmaceuticals Inc. (ABEO) | 27-Sep-23 | Purchase | 20,000 | $4.07 | $81,400.00 | 4% 501.73K to 521.73K | |
| 29-Sep-23 4:30 PM View: | Alvino Mark Director | Access Pharmaceuticals Inc. (ABEO) | 27-Sep-23 | Private Sale | 6,316 | $3.91 | $24,724.00 | (8%) 76.22K to 69.9K | |
| 29-Sep-23 4:30 PM View: | Silverstein Christine Berni Director | Access Pharmaceuticals Inc. (ABEO) | 27-Sep-23 | Private Sale | 6,330 | $3.91 | $24,721.20 | (7%) 94.21K to 87.88K | |
| 29-Sep-23 4:30 PM View: | Alland Leila Director | Access Pharmaceuticals Inc. (ABEO) | 27-Sep-23 | Private Sale | 7,246 | $3.90 | $28,269.50 | (9%) 79.1K to 71.86K | |
| 22-Sep-23 4:05 PM View: | O'Malley Brendan M. SVP, General Counsel | Access Pharmaceuticals Inc. (ABEO) | 21-Sep-23 | Payment of Exercise | 563 | $3.80 | $2,139.40 | (< 1%) 187.42K to 186.86K | |
| 22-Sep-23 4:05 PM View: | Amoroso Michael Director | Access Pharmaceuticals Inc. (ABEO) | 20-Sep-23 | Private Sale | 327 | $3.90 | $1,275.30 | (< 1%) 114.79K to 114.47K |
